413

Shares

News site default image

GSK and Verily to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic medicines

Shared by Radhika Narayanan | 0 411 2 | about 1 year ago

GSK (LSE/NYSE: GSK) today announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics to enable the research, development and commercialisation of bioelectronic medicines. GSK will hold a 55% equity interest in the new jointly owned company and Verily will hold 45%.

Read More On www.gsk.com

Categories Medtech & Devices

Related Post

Links

http://www.gsk.com/en-gb/media/press-releases/2016/gsk-and-verily-to-establish-galvani-bioelectronics-a-new-company-dedicated-to-the-development-of-bioelectronic-medicines/
http://bit.ly/2azaL6J

1 Votes

You must log in to post a comment

0 Comments